N/A
Manufactured by CareFusion 213 LLC
9,167 FDA adverse event reports analyzed
Last updated: 2026-04-15
CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CareFusion 213 LLC. The most commonly reported adverse reactions for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL include SINUSITIS, PAIN, LOWER RESPIRATORY TRACT INFECTION, PRURITUS, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL.
Out of 300 classified reports for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 9,167 FDA FAERS reports that mention CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include SINUSITIS, PAIN, LOWER RESPIRATORY TRACT INFECTION, PRURITUS, RASH, JOINT SWELLING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list CareFusion 213 LLC in connection with CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL. Always verify the specific product and NDC with your pharmacist.